You are here

Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort ascending
2010 R21 CA151128 RFA-CA-09-008 SOUSA, RUI J. UNIVERSITY OF TEXAS HLTH SCIENCE CENTER DEVELOPMENT OF IMAGING REAGENTS TO MONITOR GTP LEVELS AND GTP/GDP RATIOS IN VIVO Complete
2014 R33 CA177333 RFA-CA-13-002 FEDERSPIEL, MARK J MAYO CLINIC ROCHESTER VALIDATING TECHNOLOGY TO OPTIMIZE ANTIBODY AFFINITY FOR TARGETING THERAPEUTICS Complete
2017 R33 CA212697 RFA-CA-16-002 KLEIN, ALLON MOSHE HARVARD MEDICAL SCHOOL Droplet microfluidic technology for single cell cancer genomics Complete
2001 R33 CA084691 PAR-98-067 MELDRUM, DEIRDRE R. UNIVERSITY OF WASHINGTON AUTOMATED MINIMAL RESIDUAL DISEASE QUANTIFICATION Complete
2003 R41 CA103103 PAR-01-105 SANTANGELO, PHILIP J VIVONETICS, INC. IN VIVO GENE EXPRESSION IMAGING FOR CANCER ANALYSIS Complete
2007 R21 CA122884 RFA-CA-07-001 BIEBERICH, CHARLES J. UNIVERSITY OF MARYLAND BALT CO CAMPUS AN INNOVATIVE APPROACH FOR PROFILING PROTEIN KINASE SUBSTRATES Complete
2009 R33 CA134304 RFA-CA-08-008 SHI, HUIDONG GEORGIA REGENTS UNIVERSITY APPLICATION OF 454 SEQUENCING TO CANCER EPIGENOMICS Complete
2013 R33 CA177462 RFA-CA-12-003 BAILEY, RYAN C UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN MESO-PLEX MIRNA AND PROTEIN PROFILING FOR CANCER DIAGNOSTICS USING CHIP-INTEGRATE Complete
2016 R43 CA203681 PAR-13-327 KING, JEFFREY S VIROGENOMICS BIODEVELOPMENT, INC. Sensitive Single Cell PhosphoCount Platform for Drug-Insensitive Cell Detection and Combination Drug Screening for Leukemia Complete
2000 R43 CA084678 PAR-98-066 BAMDAD, CYNTHIA C. MINERVA BIOTECHNOLOGIES CORPORATION RAPID ELECTRONIC DETECTION OF CELL SURFACE PROTEINS Complete
2002 R43 CA096059 PAR-01-105 LOGE, GARY SPECTRUMEDIX CORPORATION AN AUTOMATED 2D-CAPILLARY ELECTROPHORESIS SYSTEM Complete
2006 R21 CA114304 RFA-CA-06-003 SCHMITTGEN, THOMAS D OHIO STATE UNIVERSITY REAL-TIME PCR EXPRESSION PROFILING OF MICRORNA Complete
2009 R21 CA138308 RFA-CA-08-006 HELD, JASON M. BUCK INSTITUTE FOR RESEARCH ON AGING OXMRM: A TECHNIQUE TO QUANTIFY OXIDATION OF ENDOGENOUS REDOX-SENSITIVE CYSTEINES Complete
2012 R21 CA173124 RFA-CA-12-004 JANZEN, WILLIAM PERRY UNIV OF NORTH CAROLINA CHAPEL HILL CAVITATION ENHANCEMENT OF BIOSPECIMEN PROCESSING FOR IMPROVED DNA FRAGMENTATION Complete
2000 R21 CA088351 PAR-99-100 FU, XIANG-DONG UNIVERSITY OF CALIFORNIA SAN DIEGO CANCER CLASSIFICATION BASED ON MRNA ISOFORMS Complete
2002 R33 CA096309 PAR-01-104 LI, HONGHUA UNIV OF MED/DENT NJ-R W JOHNSON MED SCH A GENETIC APPROACH TO GENOME-SCALE ANALYSIS OF CANCERS Complete
2005 R21 CA116060 RFA-CA-05-003 KANDEL, EUGENE S CLEVELAND CLINIC LERNER COL/MED-CWRU REVERSIBLE PROMOTER-INSERTION FOR IN VIVO STUDIES OF MELANOMA Complete
2008 R21 CA126664 RFA-CA-07-035 BARBAS, CARLOS F SCRIPPS RESEARCH INSTITUTE ZINC FINGER RECOMBINASES FOR ENDOGENOUS GENOME TAILORING Complete
2011 R21 CA147922 RFA-CA-10-005 SANTANGELO, PHILIP J GEORGIA INSTITUTE OF TECHNOLOGY CHARACTERIZING GENE REGULATION WITH SINGLE MOLECULE SENSITIVE PROBES Complete
2015 R21 CA182375 RFA-CA-14-005 SOHN, LYDIA L UNIVERSITY OF CALIFORNIA BERKELEY ISOLATING CIRCULATING TUMOR CELLS Complete
1999 R43 CA081949 PAR-98-066 OLINER, JONATHAN D AFFYMETRIX, INC. REVERSE-ENGINEERING SIGNAL TRANSDUCTION NETWORKS Complete
2001 R43 HL069675 PAR-99-101 WILLETT, CATHERINE E PHYLONIX PHARMACEUTICALS, INC. ASSAY FOR IDENTIFYING ANGIOGENIC DRUG TARGETS Complete
2004 R43 CA107764 PAR-01-105 VYKOUKAL, JODY V ADEPTAS, INC. RARE CELL ISOLATION FOR MORPHOLOGICAL & MOLECULAR STUDY Complete
2007 R33 CA122900 RFA-CA-07-002 DOVICHI, NORMAN J UNIVERSITY OF WASHINGTON CHEMICAL CYTOMETRY FOR NEOPLASIA PROGNOSIS-BARRETT'S ESOPHAGUS Complete
2010 R21 CA140089 RFA-CA-09-008 JI, HANLEE P STANFORD UNIVERSITY MUTATION ANALYSIS OF PARAFFIN-EMBEDDED TUMORS WITH NEXT GENERATION SEQUENCING Complete
2014 R33 CA177449 RFA-CA-13-002 BLAIR, SARAH L UNIVERSITY OF CALIFORNIA SAN DIEGO NON-CIRCULATING MICROPARTICLES FOR IMPROVED LOCALIZATION AND RESECTION CANCER Complete
2001 R33 CA084740 PAR-98-067 ENGELWARD, BEVIN P. MASSACHUSETTS INSTITUTE OF TECHNOLOGY FLUORESCENCE DETECTION OF GENETIC INSTABILITY IN MICE Complete
2003 R41 CA103120 PAR-01-105 GUTHOLD, MARTIN NANOMEDICA, INC. NOVEL, SINGLE-MOLECULE APTAMER SELECTION METHOD Complete
2007 R21 CA125514 RFA-CA-07-001 STEINMAN, RICHARD A UNIVERSITY OF PITTSBURGH AT PITTSBURGH A NUCLEOSOMAL BIOSENSOR FOR IDENTIFICATION AND ISOLATION OF NUCLEAR HORMONE RECEP Complete
2009 R33 CA140039 RFA-CA-08-008 ELLEDGE, STEPHEN J BRIGHAM AND WOMEN'S HOSPITAL A MULTIPLEX GENOME-WIDE SHRNA SCREENING PLATFORM FOR CANCER-LETHAL GENE DISCOVERY Complete
2013 R33 CA177456 RFA-CA-12-003 DI CARLO, DINO UNIVERSITY OF CALIFORNIA LOS ANGELES ISOLATING CIRCULATING TUMOR CELLS USING A CENTRIFUGE ON A CHIP Complete
2016 R44 CA199194 PAR-13-327 KARSTEN, STANISLAV NEUROINDX INC. Automated Platform for Fixed Tissue Microdissection Complete
2019 R33 CA225549 RFA-CA-18-003 TAVANA, HOSSEIN UNIVERSITY OF AKRON A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery Active
2018 R33 CA228979 RFA-CA-17-011 SCHRUM, ADAM G UNIVERSITY OF MISSOURI-COLUMBIA Multiplex matrix ELISA for T cell protein-interaction networks in cancer Active
2020 R44 CA243990 PAR-18-303 GURARD-LEVIN, ZACHARY SAMDI TECH, INC. Development Of The First Label-free And High-throughput, Cell-based Assay That Reports On Specific Enzyme Activities Active
2020 R21 CA246457 RFA-CA-19-019 HATTORI, TAKAMITSU NEW YORK UNIVERSITY SCHOOL OF MEDICINE Rational Generation Of High-performance Recombinant Antibodies To Post-translational Modifications Active
2019 R33 CA229042 RFA-CA-18-003 SCHNECK, JONATHAN P JOHNS HOPKINS UNIVERSITY A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells Active
2018 R33 CA229023 RFA-CA-17-011 TEWARI, MUNEESH (contact); WALTER, NILS G UNIVERSITY OF MICHIGAN AT ANN ARBOR Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations Active
2020 R33 CA236670 RFA-CA-19-020 HIGGINSON, DANIEL SLOAN-KETTERING INST CAN RESEARCH Comprehensive Breakpoint Analyses For Simultaneous Quantification Of All Dna Double Strand Break Repair Pathways Active
2019 R33 CA229068 RFA-CA-18-003 SCHIAVINATO EBERLIN, LIVIA UNIVERSITY OF TEXAS, AUSTIN Advanced Development of the MasSpec Pen for Cancer Diagnosis and Surgical Margin Evaluation Active
2018 R21 CA229037 RFA-CA-17-012 GULLEY, MARGARET L UNIV OF NORTH CAROLINA CHAPEL HILL EndoGenus Toolkit: A Biometric Method for Absolute Quantification of Tumor Markers by Massive Parallel Sequencing Active
2020 R21 CA240185 RFA-CA-19-019 LI, WEI TEXAS TECH UNIVERSITY Fractionation And Profiling Of Heterogeneous Circulating Tumor Cells Using A Hyperuniform- Structured Microchip Active
2019 R33 CA235254 RFA-CA-18-003 FIOLKA, RETO PAUL UT SOUTHWESTERN MEDICAL CENTER Multiscale microscope for 3D cancer imaging in model organisms and organoids Active
2020 R21 CA247638 RFA-CA-19-019 LIANG, FU-SEN CASE WESTERN RESERVE UNIVERSITY Spatiotemporal Epitranscriptome Editing Technology Active
2019 R33 CA235302 RFA-CA-18-003 DE VLAMINCK, IWIJN CORNELL UNIVERSITY Spatially Resolved Metagenomics to Explore Tumor-Microbiome Interactions in Human Colorectal Cancer Active
2020 R44 CA236097 PAR-18-303 LIM, MARK AMBERGEN, INC Highly Multiplexed Nanoscale Mass Spectrometric Imaging Of Cancer Tissues Active
2019 R33 CA235319 RFA-CA-18-003 YANG, JENNY J. GEORGIA STATE UNIVERSITY Multi-color Mapping of Cancer Molecular Signatures and Tumor microenvironment Active
2018 R33 CA217702 RFA-CA-17-013 BORGES, CHAD R ARIZONA STATE UNIVERSITY-TEMPE CAMPUS Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity Active
2020 R43 CA250885 PAR-18-303 REDER, NICHOLAS LIGHTSPEED MICROSCOPY, INC. Open-top Light-sheet Microscopy For Non-destructive 3d Pathology Of Prostate Biopsies Active
2019 R33 CA235597 RFA-CA-18-003 SOPER, STEVEN ALLAN UNIVERSITY OF KANSAS LAWRENCE Increased Sensitivity of Minimal Residual Disease Monitoring using Peripheral Blood in Pediatric Patients with Acute Lymphoblastic Leukemia Active

Pages



National Cancer Institute at the National Institutes of Health

 

NIH… Turning Discovery Into Health®